Seelos Therapeutics, Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (8)

Latest Posts

About This Stock More About This Stock
April Psychedelic Drug Stocks Recap: The Ups And Downs
Article By: Lorimer Wilson
Sunday, April 30, 2023 11:50 AM EDT
The April and YTD performances of the psychedelic drug stocks we track in our index, vary pretty widely from company to company, but almost universally are expected to rise substantially.
In this article: ATAI, MNMD, CMPS, SEEL, GHRS, CYBN, IXHL
Read
Largest Psychedelic Stocks -3.4% In March
Article By: Lorimer Wilson
Sunday, April 2, 2023 1:28 AM EDT
The munKNEE Psychedelic Drug Stocks Index was down 3.4% in March but is still +1.2% YTD. The best news is the continuing high price targets being set by analysts.
In this article: ATAI, MNMD, CMPS, SEEL, GHRS, CYBN, IXHL
Read
Seelos Addressing Significant And Unmet Needs In Rare Psychiatric And Movement Disorders
Article By: Lorimer Wilson
Friday, March 10, 2023 11:30 AM EDT
The progress Seelos is achieving in its multi-faceted clinical trials has investors taking a long hard look at what it's all about.
In this article: SEEL
Read
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
Article By: Lorimer Wilson
Sunday, February 26, 2023 11:54 AM EDT
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage likelihood of it going bankrupt within the next 2 years.
In this article: ATAI, PSIL, MNMD, CMPS, SEEL, GHRS, CYBN
Read
"Multi-Bagger" Portfolio Update
Article By: Lorimer Wilson
Sunday, February 12, 2023 6:34 PM EDT
Cannabis, psychedelic and plant-based food stocks were extremely oversold in 2022. I'm tracking 12 microcap stocks that might bounce back with major returns - dare I say "multi-bagger" returns.
In this article: ACRDF, AYR, MNMD, PLNHF, TTCF, SEEL, CYBN
Read

Latest Tweets for $SEEL

No tweets yet!

PARTNER HEADLINES